Effectiveness of metformin as an adjunctive therapy in rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials
Manar M. Alshammari, Noor A. Abood, Sundus Kahwaji, Fatemeh Sharif-Askari, Hala Alobaidi, Zelal Kharaba, Feras Jirjees · 2026
Read Effectiveness of metformin as an adjunctive therapy in rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials by Manar M. Alshammari, Noor A. Abood, Sundus Kahwaji, Fatemeh Sharif-Askari, Hala Alobaidi, Zelal Kharaba, Feras Jirjees (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13563912.txt.
Description
Manar M. Alshammari and co-authors present a 2026 systematic review and meta-analysis asking whether metformin, added to standard rheumatoid arthritis drugs, improves disease control. Four randomized trials with 350 participants were found through searches of four databases up to the end of 2025, and trial quality was checked with a standard risk-of-bias tool.
After three months, patients receiving metformin showed lower inflammation scores, lower disease activity scores, and less disability than comparison groups in the pooled results. Because only four small trials were available, the findings read as promising rather than settled. Clinicians get a compact summary of what the limited trial evidence can and cannot support.
Catalog record
| CREATOR | Manar M. Alshammari, Noor A. Abood, Sundus Kahwaji, Fatemeh Sharif-Askari, Hala Alobaidi, Zelal Kharaba, Feras Jirjees |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43524 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |